Skip to main content
Top
Published in: AIDS and Behavior 9/2014

01-09-2014 | Original Paper

Adherence to Rectal Gel Use Among Mainly Ethnic Minority Young Men Who have Sex with Men During A 3-Month Placebo Gel Trial: Implications for Microbicide Research

Authors: Alex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, José Bauermeister, Cheng-Shiun Leu, Juan Valladares, Timothy Frasca, Rita Labbett, Ross D. Cranston, Irma Febo, Kenneth Mayer, Ian McGowan

Published in: AIDS and Behavior | Issue 9/2014

Login to get access

Abstract

To study adherence to product use prior to a Phase I microbicide trial, we recruited young men who have sex with men (YMSM) with a history of unprotected receptive anal intercourse (RAI) and provided them with 40 rectal applicators containing a placebo gel to use prior to RAI during a 12-week period. Ninety-five YMSM completed the trial. Based on a Computer Assisted Self Interview, 83 participants had receptive anal intercourse (RAI) (Median 12 occasions) using gel on 82.4 % of occasions (SD 26.7; 0–100). Based on an interactive voice response system, 88 participants had RAI (Median 10 occasions) using gel on 87.9 % of occasions (SD 20.0; 20–100). By applicator counts the median gel use was 12. Participants showed high adherence to gel use. Those who did not use the product consistently (n = 40) adduced not having it with them (85 %), forgetting to use it (48 %), not wanting to use it (13 %), partner refusal (10 %) and gel messiness (10 %).
Literature
1.
2.
go back to reference Agashe H, Hu M, Rohan L. Formulation and delivery of microbicides. Curr HIV Res. 2012;10(1):88–96.PubMedCrossRef Agashe H, Hu M, Rohan L. Formulation and delivery of microbicides. Curr HIV Res. 2012;10(1):88–96.PubMedCrossRef
3.
go back to reference Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.PubMedCentralPubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.PubMedCentralPubMedCrossRef
5.
go back to reference Van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS Lond Engl. 2012;26(7):F13–9.CrossRef Van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS Lond Engl. 2012;26(7):F13–9.CrossRef
6.
go back to reference Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, et al. RMP-02/MTN-006: a phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1 % gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retrovir. 2012;28(11):1412–21.PubMedCentralPubMedCrossRef Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, et al. RMP-02/MTN-006: a phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1 % gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retrovir. 2012;28(11):1412–21.PubMedCentralPubMedCrossRef
7.
go back to reference McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, et al. A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1 % gel (MTN-007). PLoS ONE. 2013;8(4):e60147.PubMedCentralPubMedCrossRef McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, et al. A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1 % gel (MTN-007). PLoS ONE. 2013;8(4):e60147.PubMedCentralPubMedCrossRef
8.
go back to reference Tabet SR, Surawicz C, Horton S, Paradise M, Coletti AS, Gross M, et al. Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999;26(10):564–71.PubMedCrossRef Tabet SR, Surawicz C, Horton S, Paradise M, Coletti AS, Gross M, et al. Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999;26(10):564–71.PubMedCrossRef
10.
go back to reference Carballo-Diéguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.PubMedCentralPubMedCrossRef Carballo-Diéguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.PubMedCentralPubMedCrossRef
11.
go back to reference Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.PubMedCrossRef Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.PubMedCrossRef
12.
go back to reference Celentano DD, Sifakis DF, Hylton DJ, Torian DLV, Guillin DV, Koblin DBA. Race/ethnic differences in HIV prevalence and risks among adolescent and young adult men who have sex with men. J Urban Health. 2005;82(4):610–21.PubMedCentralPubMedCrossRef Celentano DD, Sifakis DF, Hylton DJ, Torian DLV, Guillin DV, Koblin DBA. Race/ethnic differences in HIV prevalence and risks among adolescent and young adult men who have sex with men. J Urban Health. 2005;82(4):610–21.PubMedCentralPubMedCrossRef
13.
go back to reference Sifakis F, Hylton JB, Flynn C, Solomon L, MacKellar DA, Valleroy LA, et al. Racial disparities in HIV incidence among young men who have sex with men. JAIDS J Acquir Immune Defic Syndr. 2007;46(3):343–8.CrossRef Sifakis F, Hylton JB, Flynn C, Solomon L, MacKellar DA, Valleroy LA, et al. Racial disparities in HIV incidence among young men who have sex with men. JAIDS J Acquir Immune Defic Syndr. 2007;46(3):343–8.CrossRef
15.
go back to reference Carballo-Diéguez A, Remien RH, Dolezal C, Wagner G. Reliability of sexual behavior self-reports in male couples of discordant HIV status. J Sex Res. 1999;36(2):152–8.CrossRef Carballo-Diéguez A, Remien RH, Dolezal C, Wagner G. Reliability of sexual behavior self-reports in male couples of discordant HIV status. J Sex Res. 1999;36(2):152–8.CrossRef
16.
go back to reference Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE. 2010;5(7):e11600.PubMedCentralPubMedCrossRef Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE. 2010;5(7):e11600.PubMedCentralPubMedCrossRef
18.
go back to reference Eaton L, Kalichman SC, Cain D, Cherry C, Stearns H, Amaral C, et al. Serosorting sexual partners and continued risk for HIV transmission among men who have sex with men. Am J Prev Med. 2007;33(6):479–85.PubMedCentralPubMedCrossRef Eaton L, Kalichman SC, Cain D, Cherry C, Stearns H, Amaral C, et al. Serosorting sexual partners and continued risk for HIV transmission among men who have sex with men. Am J Prev Med. 2007;33(6):479–85.PubMedCentralPubMedCrossRef
19.
go back to reference Carballo-Diéguez A, Giguere R, Dolezal C, Chen BA, Kahn J, Zimet G, et al. “Tell Juliana”: acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study. AIDS Behav. 2012;16(7):1761–74.PubMedCentralPubMedCrossRef Carballo-Diéguez A, Giguere R, Dolezal C, Chen BA, Kahn J, Zimet G, et al. “Tell Juliana”: acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study. AIDS Behav. 2012;16(7):1761–74.PubMedCentralPubMedCrossRef
20.
go back to reference Keller MJ, Buckley N, Katzen LL, Walsh J, Friedland B, Littlefield S, et al. Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex. Sex Transm Dis. 2013;40(12):939–43.PubMedCrossRef Keller MJ, Buckley N, Katzen LL, Walsh J, Friedland B, Littlefield S, et al. Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex. Sex Transm Dis. 2013;40(12):939–43.PubMedCrossRef
21.
go back to reference Mauck CK, Schwartz JL. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. Sex Transm Dis. 2012;39(9):713–5.PubMedCrossRef Mauck CK, Schwartz JL. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. Sex Transm Dis. 2012;39(9):713–5.PubMedCrossRef
22.
go back to reference Moench TR, O’Hanlon DE, Cone RA. Evaluation of Microbicide Gel Adherence Monitoring Methods. Sex Transm Dis. 2012;39(5):335–40.PubMedCrossRef Moench TR, O’Hanlon DE, Cone RA. Evaluation of Microbicide Gel Adherence Monitoring Methods. Sex Transm Dis. 2012;39(5):335–40.PubMedCrossRef
23.
go back to reference Van der Straten A, Cheng H, Mensch B, Friedland B, Katzen L, Littlefield S, et al. Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials. Sex Transm Dis. 2013;40(12):950–6.PubMedCrossRef Van der Straten A, Cheng H, Mensch B, Friedland B, Katzen L, Littlefield S, et al. Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials. Sex Transm Dis. 2013;40(12):950–6.PubMedCrossRef
Metadata
Title
Adherence to Rectal Gel Use Among Mainly Ethnic Minority Young Men Who have Sex with Men During A 3-Month Placebo Gel Trial: Implications for Microbicide Research
Authors
Alex Carballo-Diéguez
Rebecca Giguere
Curtis Dolezal
José Bauermeister
Cheng-Shiun Leu
Juan Valladares
Timothy Frasca
Rita Labbett
Ross D. Cranston
Irma Febo
Kenneth Mayer
Ian McGowan
Publication date
01-09-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0768-1

Other articles of this Issue 9/2014

AIDS and Behavior 9/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.